Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Jessup Website

John M. Jessup, M.D.

Selected Publications

1)  Parkinson DR, McCormack RT, Keating SM, Gutman SI, Hamilton SR, Mansfield EA, Piper MA, Deverka P, Frueh FW, Jessup JM, McShane LM, Tunis SR, Sigman CC, Kelloff GJ.
Evidence of clinical utility: an unmet need in molecular diagnostics for patients with cancer.
Clin. Cancer Res. 20: 1428-44, 2014.
[Journal]
2)  Williams PM, Lively TG, Jessup JM, Conley BA.
Bridging the gap: moving predictive and prognostic assays from research to clinical use.
Clin. Cancer Res. 18: 1531-9, 2012.
[Journal]
3)  Meshinchi S, Hunger SP, Aplenc R, Adamson PC, Jessup JM.
Lessons learned from the investigational device exemption review of Children's Oncology Group trial AAML1031.
Clin. Cancer Res. 18: 1547-54, 2012.
[Journal]
4)  Poste G, Carbone DP, Parkinson DR, Verweij J, Hewitt SM, Jessup JM.
Leveling the playing field: bringing development of biomarkers and molecular diagnostics up to the standards for drug development.
Clin. Cancer Res. 18: 1515-23, 2012.
[Journal]
5)  Zhang J, Espinoza LA, Kinders RJ, Lawrence SM, Pfister TD, Zhou M, Veenstra TD, Thorgeirsson SS, Jessup JM.
NANOG modulates stemness in human colorectal cancer.
Oncogene. [Epub ahead of print], 2012.
[Journal]
6)  Zwart SR, Jessup JM, Ji J, Smith SM.
Saturation diving alters folate status and biomarkers of DNA damage and repair.
PLoS ONE. 7: e31058, 2012.
[Journal]
7)  Smalley SR, Benedetti JK, Haller DG, Hundahl SA, Estes NC, Ajani JA, Gunderson LL, Goldman B, Martenson JA, Jessup JM, Stemmermann GN, Blanke CD, Macdonald JS.
Updated Analysis of SWOG-Directed Intergroup Study 0116: A Phase III Trial of Adjuvant Radiochemotherapy Versus Observation After Curative Gastric Cancer Resection.
J. Clin. Oncol. 30: 2327-33, 2012.
[Journal]
8)  Jessup J, Gunderson L, Compton C.
Colon And Rectum. In: AJCC Cancer Staging Manual. Volume 7th Edition.
New York: Springer; 2010. p. 143-164 [Book Chapter]
9)  Sobin LH, Compton CA, Gospodarowicz M, Greene FL, Gunderson LL, Jessup JM, Wittekind C.
'Evidence-based medicine: the time has come to set standards for staging'. Is a radical overhaul really needed?.
J. Pathol. 221: 361-2, 2010.
[Journal]
10)  Dancey JE, Dobbin KK, Groshen S, Jessup JM, Hruszkewycz AH, Koehler M, Parchment R, Ratain MJ, Shankar LK, Stadler WM, True LD, Gravell A, Grever MR.
Guidelines for the development and incorporation of biomarker studies in early clinical trials of novel agents.
Clin. Cancer Res. 16: 1745-55, 2010.
[Journal]
Click Here to View Expanded Bibliography.

This page was last updated on 5/2/2014.